Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: Turkey (Türkiye) Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20153
20161
20172
20181
20193
20201
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Hoffmann-La Roche2
Rainier Therapeutics2
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
Incyte Corporation1
Janssen Research & Development, LLC1
Klus Pharma Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell15
Urinary Bladder Neoplasms7
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Urinary Bladder Diseases2
Urologic Diseases2
Uterine Cervical Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.